February 26, 2015 7:44 PM ET


Company Overview of VLST Corporation

Company Overview

VLST Corporation discovers and develops therapeutics for the treatment of inflammatory and autoimmune disorders. The company provides VLST-007 (hCD47-hFc), a dimeric protein for the treatment of inflammatory and autoimmune diseases; VLST-002 (AntiKine Ab) multi-reactive anti-chemokine antibodies for the treatment of autoimmune and inflammatory diseases; and Hepatitis C virus antiviral products. Its discovery platform has primary applications for the treatment of inflammatory and autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, lupus, and diabetes. The company was founded in 2004 and is headquartered in Seattle, Washington.

307 Westlake Avenue North

Suite 300

Seattle, WA 98109

United States

Founded in 2004





Key Executives for VLST Corporation

Executive Chairman
Age: 61
Co-Founder and Chairman of the Scientific Advisory Board
Vice President of Finance & Administration
Board Observer
Age: 63
Board Observer
Age: 51
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Kedrion Biopharma Inc. United States
GenoRx, Inc. United States
Adjuvance Technologies, Inc. United States
Phylogeny, Inc. United States
Asuragen, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VLST Corporation, please visit www.vlstcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.